Beneficial Effects of a Dual Cyclooxygenase Inhibitor−Thromboxane Antagonist in Counteracting High-Fat Diet-Induced Metaflammation
Chronic low-grade inflammation (metaflammation) is a key contributor to obesity-associated metabolic disorders and their cardiovascular complications. This study investigated the effects of CXT29, a novel dual cyclooxygenase-2 (COX-2) inhibitor and thromboxane prostanoid receptor (TP) antagonist, in comparison with its...